Position in ALKS
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$2,155,793
-$2,309,283 QoQ
Shares Held
60,967
-61.8% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026INTECH INVESTMENT MANAGEMENT LLC holds $94,314,635 across 29 Drug Manufacturers - Specialty & Generic names. ALKS ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
311,871 | $36,866,270 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
478,939 | $14,425,641 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
20,744 | $12,300,776 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
86,315 | $11,371,137 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
44,826 | $3,400,052 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
88,945 | $2,711,043 | |
| 7 | ALKS |
Alkermes plc.
This page
|
60,967 | $2,155,793 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
38,984 | $2,015,082 |
All Filings in ALKS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,155,793 | 60,967 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $4,465,076 | 159,581 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,221,110 | 74,037 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,423,524 | 84,709 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,825,323 | 85,564 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $1,960,022 | 68,151 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,463,121 | 52,273 | Shares | Sole | 2024-11-08 | |
| No filing history on record for this holder in this stock. | ||||||